ACTIVE

PHARMACIE MONTENEGRO

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result16 k €+364,2 %over 1 year
Gross margin248,2 k €+21,9 %over 1 year
Equity81,1 k €+24,6 %over 1 year
Workforce2,5 ETP-3,8 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE MONTENEGRO is a Private limited company incorporated in 2021. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Anderlecht. It employs on average 2,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0764.411.765
Incorporation
26/02/2021
Legal form
Private limited company
Registered office
Drève des Agaves 9
1070 Anderlecht · BruxellesSee on map
Contributed capital
100 000,00 €
Latest accounts
31/12/2025
Average workforce
2,5 ETP
Joint committees (1)
  • 313
Contacts
2 public details availableLog in to view
Signals
ProfitablePositive cashflowPositive EBITDA

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20252024202320222021
Income statement
Gross margin248,2 k €203,6 k €152,1 k €235,8 k €17,8 k €
EBITDA129,6 k €94,8 k €47,2 k €115,9 k €17,8 k €
Operating result54,6 k €19,9 k €-27,8 k €40,7 k €15,9 k €
Net result16 k €-6,1 k €-44,2 k €8,7 k €6,7 k €
Balance sheet
Equity81,1 k €65,1 k €71,2 k €115,4 k €106,7 k €
Total assets791,1 k €839,6 k €948,8 k €1,2 M €922,1 k €
Cash84,9 k €62,2 k €136 k €296,4 k €53,4 k €
Debts710 k €774,4 k €877,6 k €1 M €815,3 k €
Other
Workforce2,5 ETP2,6 ETP1,9 ETP1,9 ETP–

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 1 ended

Active mandates

ALI EMDADI MILAD

Director

Active
ZACHARIA BOUMEDIENNI

Director

Active

Ended mandates

MILAD EMDADI

Director

Ended

Other companies at this address

Drève des Agaves 9 1070 Anderlecht
CompanyCBE no.
MARIA EL MOURABI● Active
0679.616.543
PHARMA DISCOUNT● Active
0769.949.871
PHARMALAW● Active
0679.616.642
PHARMATRUST● Active
0696.779.308

Full financial information

Source · NBB
20252024202320222021
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202224/02/2021
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/2021
Length of the financial year12 months12 months12 months12 months11 months
Filing date31/08/202628/08/202530/08/202430/05/202305/09/2022
General meeting29/05/202630/05/202531/05/202426/05/202327/05/2022
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/05/202631/08/2026FrenchPDF
Abridged model31/12/202430/05/202528/08/2025FrenchPDF
Abridged model31/12/202331/05/202430/08/2024FrenchPDF
Abridged model31/12/202226/05/202330/05/2023FrenchPDF
Abridged model31/12/202127/05/202205/09/2022FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 1 ended

Active mandates

ALI EMDADI MILAD

Director

Active
ZACHARIA BOUMEDIENNI

Director

Active

Ended mandates

MILAD EMDADI

Director

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates07/02/2022
    DENOMINATION - DIVERS - SIEGE SOCIAL
    PDF
  • Restructuring08/12/2021
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Other02/03/2021
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202516 k €↑
  2. 2024
    Annual accounts 2024-6,1 k €↑
  3. 2024
    Name changeMONTENEGRO PHARMACIE
  4. 2023
    Annual accounts 2023-44,2 k €↓
  5. 2022
    Annual accounts 20228,7 k €↑
  6. 2022
    Name changePHARMACIE MONTENEGRO
  7. 2021
    Annual accounts 20216,7 k €
  8. 26/02/2021
    IncorporationPrivate limited company
  9. 2021
    Name changePHARMATWIN